Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sanuwave Health Inc. (SNWV)
:SNWV
Earnings Data
Report Date
Apr 08, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
―Last Year’s EPS
0.02Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 08, 2024
|% Change Since: 39.18%
|Next Earnings Date:Apr 08, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted significant achievements, including record revenues, substantial growth in UltraMIST sales, improved profitability, and successful financial restructuring. However, challenges remain, such as ongoing net losses, difficulties in revenue forecasting due to customer complexities, and existing material weaknesses in internal controls.Company Guidance
In the recent earnings call for SANUWAVE, the company provided optimistic guidance for the upcoming quarter, projecting revenues between $9.7 million and $10.5 million, which signifies a 40% to 50% growth compared to Q4 2023. This would lead to an estimated total revenue of over $32 million for the entirety of 2024, representing a 57% year-on-year increase. SANUWAVE also reported a record-breaking Q3 2024, with revenues of $9.4 million, marking an 89% rise from the previous year and a 31% sequential growth from Q2 2024. The company achieved a gross margin of 75.5% and recorded $2 million in operating profit alongside $2.1 million in adjusted EBITDA. Additionally, SANUWAVE has made significant progress in stabilizing its financial structure, having repaid certain debts and regained compliance with loan covenants. The company is also considering an uplisting to NASDAQ, aiming to meet the market value standard requirements in the near future.Record Quarterly Revenue
SANUWAVE announced the highest quarterly revenues in company history, achieving $9.4 million in Q3 2024, marking an 89% increase year-over-year and 31% sequential growth from Q2 2024.
UltraMIST Revenue Growth
UltraMIST revenue, which was approximately 58% of the company's revenue in the quarter, grew 75% year-over-year and 14% sequentially versus Q2 2024.
Significant Operating Profit and Improved Margins
The company reported $2 million of operating profit and $2.1 million of adjusted EBITDA for the quarter, with gross margins rising to 75.5%.
Successful Funding and Debt Management
SANUWAVE closed a $10.3 million PIPE deal, repaid certain debt, and regained compliance with loan covenants, simplifying and stabilizing the company's capital structure.
Positive Cash Flow
The company became cash generative for Q3 2024 as a whole, even after cash interest costs.
---
SNWV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SNWV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 08, 2024 | $19.40 | $22.20 | +14.43% |
| Aug 13, 2024 | $5.78 | $6.00 | +3.81% |
| May 10, 2024 | $8.25 | $8.59 | +4.12% |
| Mar 22, 2024 | $7.50 | $7.41 | -1.20% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Sanuwave Health Inc. (SNWV) report earnings?
Sanuwave Health Inc. (SNWV) is schdueled to report earning on Apr 08, 2025, TBA Not Confirmed.
What is Sanuwave Health Inc. (SNWV) earnings time?
Sanuwave Health Inc. (SNWV) earnings time is at Apr 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SNWV EPS forecast?
Currently, no data Available
---